Format

Send to

Choose Destination
Curr Opin Mol Ther. 2001 Feb;3(1):31-6.

DNA shuffling and vaccines.

Author information

1
Maxygen Inc, 515 Galveston Drive, Redwood City, CA 94063, USA. robert.whalen@maxygen.com

Abstract

One challenge of biotechnology is to find ways to optimize enzymes, cytokines, vaccines or transgenes in new contexts that are typically not found in nature. The approach of DNA shuffling is a test-tube process that takes advantage of recombination to generate libraries of chimeric genes, which can then be screened to identify the encoded proteins improved in one or more functions. DNA shuffling of two or more genes that are structurally similar and homologous in function is particularly efficacious in generating large libraries of functionally novel molecules. Other directed evolution methods, such as those involving directed or random mutagenesis, have several limitations compared to the DNA shuffling recombination process. A wide variety of genes have been submitted to DNA shuffling, and significant improvements in various functional parameters have been obtained. Several examples of the application of DNA shuffling to vaccine development, therapeutics and gene therapy are discussed here.

PMID:
11249729
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center